Stocks›Healthcare›TYRA

TYRA

Tyra Biosciences, Inc.

NasdaqResearch view

$21.76−2.90%

Sep 25 close · 1D EOD · Databento

HealthcarePharmaceutical Preparations

What happened

Daily closes · dots are Wire stories

1 story has a settled receipt so far (1 on the Wire). The record starts speaking at three.

What’s next

Expected around early November, going by its own filing history. The company has not announced a date yet. Its matching report came Nov 5, 2025 and Nov 7, 2024, after the close.

Last report

Aug 4, 2026

after the close

Every report since 2022 →

DateEventSourceNext close

Sep 14Tyra Announces Pricing of $400 Million Underwritten Offering of Common Stock and Pre-Funded WarrantsPR NewswirePR Newswire+13.80%
Aug 4Earnings release, after the close · 8-KSEC EDGARSEC EDGAR ↗—AWAITING

Next close = the first close after the event against the close before it. Prior-session closes only; not a call, not advice.

Follow the news. Track the move.

TYRA story timeline

Company updates and connected market context, with the dated price move attached.

Stories

Direct

TYRA direct/Earnings

Sep 14

Tyra Announces Pricing of $400 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Tyra Biosciences announced a $400 million underwritten offering of common stock and pre-funded warrants. The financing expands the company’s capital base but creates near-term dilution pressure for existing shareholders.

Since story

-13.2%

2026-09-14 → 2026-09-25

PR Newswire · 14d ago

View both sides →

Follow the news. Track the move.